GEORGE TOWN: A Malaysia-based biotech company is set to develop a vaccine in eight years for the EV71 virus, which causes the infectious and potentially fatal hand, foot and mouth disease (HFMD).
The company embarking on this ambitious task is Sentinext Therapeutics Sdn Bhd with its laboratory in Universiti Sains Malaysia (USM), Penang.
Already a subscriber? Log in
The Star 6.6 DEAL: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
